EyePoint Pharmaceuticals, Inc. (EYPT)

NASDAQ: EYPT · Real-Time Price · USD

11.01

+0.26 (2.42%)

At close: Aug 13, 2025, 4:00 PM

11.20

+0.19 (1.72%)

Pre-market: Aug 14, 2025, 8:05 AM EDT

EyePoint Pharmaceuticals Market Cap

EyePoint Pharmaceuticals has a market cap or net worth of $758.89 million as of August 14, 2025. Its market cap has increased by 53.87% in one year.

Market Cap

758.89M

Enterprise Value

526.87M

1-Year Change

53.87%

Ranking

#2686

Market Cap Chart

Since January 27, 2005, EyePoint Pharmaceuticals's market cap has increased from $388.60M to $758.89M, an increase of 95.29%. That is a compound annual growth rate of 3.31%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	758.90M	49.24%
Dec 31, 2024	508.50M	-37.68%
Dec 29, 2023	816.00M	583.99%
Dec 30, 2022	119.30M	-66.13%
Dec 31, 2021	352.20M	273.09%
Dec 31, 2020	94.40M	-43.68%
Dec 31, 2019	167.60M	-6.53%
Dec 31, 2018	179.30M	266.67%
Dec 29, 2017	48.90M	-16.27%
Dec 30, 2016	58.40M	-58.82%
Dec 31, 2015	141.80M	17.58%
Dec 31, 2014	120.60M	12.71%
Dec 31, 2013	107.00M	279.43%
Dec 31, 2012	28.20M	22.08%
Dec 30, 2011	23.10M	-75.61%
Dec 31, 2010	94.70M	44.14%
Dec 31, 2009	65.70M	281.98%
Dec 31, 2008	17.20M	-70.19%
Dec 31, 2007	57.70M	-25.93%
Dec 29, 2006	77.90M	-62.73%
Dec 30, 2005	209.00M	-46.22%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	570.26B
Johnson & Johnson	418.62B
AbbVie	350.91B
AstraZeneca	229.47B
UnitedHealth Group	228.94B
Novartis AG	228.69B
Abbott Laboratories	228.63B
Novo Nordisk	222.88B

Market Cap Rankings